| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $2.7M | +5.4% | +107.2% |
| SG&A Expense | $1.4M | +6.6% | +4.5% |
| Operating Income | -$794K | +66.8% | +77.9% |
| Pre-tax Income | -$616K | +72.8% | +81.9% |
| Income Tax | -$643K | -473.9% | — |
| Net Income | $27K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.5M | +435.7% | -2.3% |
| Short-term Investments | $13.9M | -29.4% | -40.7% |
| Accounts Receivable | $1.2M | -49.8% | -32.0% |
| Current Assets | $22.7M | -8.3% | -28.3% |
| Total Assets | $29.9M | -6.5% | -22.5% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.8M | — | — |
| Capital Expenditures | $33K | — | — |
| Investing Cash Flow | $9.1M | — | — |
| Financing Cash Flow | $265K | — | — |
| Free Cash Flow | -$7.8M | — | — |
| +100.8% |
| EPS (Basic) | $0.01 | +101.9% | +101.2% |
| EPS (Diluted) | $0.01 | +101.9% | +101.2% |
| $2.6M |
| -19.0% |
| -26.9% |
| Total Liabilities | $7.5M | -24.1% | -12.1% |
| Stockholders' Equity | $22.4M | +1.3% | -25.4% |